Evolva Aktie

Kaufen

Verkaufen

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Bei einem anderen Broker handeln

WKNA0EAKH

ISINCH0021218067

SymbolELVAF

Evolva Aktien News

Sortieren:Datum Meistgelesen

12.04.24EQS GroupShareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected

26.03.24EQS GroupApproval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules

22.03.24EQS GroupEvolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g

07.03.24EQS GroupEvolva Holding SA in liquidation: Nice & Green requests 3 agenda items be included in AGM agenda

28.12.23EQS GroupEvolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023

21.12.23EQS GroupShareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting

30.11.23EQS GroupEvolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc.

21.11.23EQS GroupEvolva enters into an agreement to sell its operations to Lallemand, securing the best possible outcome for the company and its stakeholders

14.11.23EQS GroupEvolva and Breko broaden partnership by signing agreement for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam

28.09.23EQS GroupEvolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries

13.09.23EQS GroupEvolva and Nice & Green agree on improvements to financing agreement

06.09.23EQS GroupEvolva receives approval for Veri-teTM Resveratrol in Thailand

24.08.23EQS GroupEvolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023

24.08.23EQS GroupEvolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges

28.07.23EQS GroupEvolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year

25.07.23EQS GroupEvolva receives approval for Veri-teTM Resveratrol in Taiwan

26.06.23EQS GroupEvolva Holding SA: Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives

14.06.23EQS GroupEvolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance

05.05.23EQS GroupEvolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026

24.04.23EQS GroupEvolva publishes timeline of the Reverse Stock Split

18.04.23EQS GroupEvolva shareholders approve all motions proposed by the Board at todays Annual General Meeting

28.03.23EQS GroupEvolva goes Responsible Care at in-cosmetics 2023

24.03.23EQS GroupEvolva publishes agenda for 2023 Annual General Meeting

09.03.23EQS GroupEvolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile

06.03.23EQS GroupEvolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative

11.01.23EQS GroupEvolva delivers strong results with 57% revenue growth and increasing margins

14.12.22EQS GroupEvolva launches its Natural Nootkatone

12.12.22EQS GroupEvolva statement to SER communication

29.11.22EQS GroupEvolva: Update on activities to boost Resveratrol

10.11.22EQS GroupEvolva receives approval for Veri-teTM Resveratrol for animal health in Brazil

21.10.22EQS GroupEvolva receives grant from US CDC in the amount of USD 540,000

11.10.22EQS GroupEvolvas NootkaSHIELDTM insect repellent approved in Hong Kong

06.10.22EQS GroupEvolva business update: Continued good business momentum

Evolva News

Evolva News: auf dieser Seite finden Sie alle Evolva News und Nachrichten zur Evolva Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Evolva News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Evolva News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.